Latest News and Press Releases
Want to stay updated on the latest news?
-
Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX)...
-
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report provides critical insights, including market size...
-
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market Size, Share & Trends Analysis Report by Treatment (Appetite Stimulants, Corticosteroids), Type (Lung Cancer, Colorectal...
-
Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - A Global and Regional Analysis: Focus on Therapy Type, Stage of Cachexia, Distribution Channel, and Region - Analysis and...
-
New York, USA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cancer Cachexia Clinical Trial Pipeline Shows Potential with Active Contributions from 18+ Key Companies | DelveInsight The cancer cachexia...
-
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Cachexia Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global cancer cachexia market is forecast to...
-
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cancer Cachexia Market to Reach...
-
Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global cancer cachexia market was projected to attain US$ 2.2 billion in 2022. It is...
-
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The global cancer cachexia market accounted for USD 2,554 million in 2022. The cancer cachexia market is set for rapid growth and expected to reach USD...
-
WASHINGTON, D.C., Oct. 12, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) released their Cancer Cachexia Voice of the Patient Report as a follow-up to their Externally-Led Patient...